Download PDF
Transfusionsmedizin 2022; 12(03): 169-182
DOI: 10.1055/a-1720-8217
CME-Fortbildung

Klonale Hämatopoese – Verbindungsglied kardiovaskulärer und hämatologischer Erkrankungen

Clonal Hematopoiesis as Link between Cardiovascular and Hematologic Disorders
Mareike Frick
,
Frederik Damm
› Further Information
Also available at
    Permissions and Reprints

Klonale Hämatopoese ist ein prämaligner Zustand der Blutzellen, der insbesondere in der älteren Bevölkerung sehr häufig ist. Er geht nicht nur mit einem erhöhten Risiko für hämatologische Erkrankungen einher, sondern ist insbesondere aufgrund des vermehrten Vorkommens von kardiovaskulären Erkrankungen klinisch hochrelevant. Auch im Kontext allogener hämatopoetischer Stammzelltransplantationen spielt klonale Hämatopoese eine zunehmend wichtige Rolle.

Abstract

Clonal hematopoiesis is an acquired premalignant condition of blood cells. It is very frequent in the elderly population and is associated with an increased risk of hematologic disorders and cardiovascular diseases. Likewise, clonal hematopoiesis plays a critical role in the development of therapy-related myeloid neoplasms. In case of donor clonal hematopoiesis, transplantation outcome differs in various parameters compared to transplantations with donors who do not have clonal hematopoiesis. Finally, donor cell leukemia is a rare but devastating complication of allogeneic transplantation that is more frequent in specific constellations of donor clonal hematopoiesis.

Schlüsselwörter

klonale Hämatopoese - hämatopoetische Stammzelle - Mutation - Chemotherapie - hämatopoetische Stammzelltransplantation

Key words

clonal hematopoiesis - hematopoietic stem cell - mutation - chemotherapy - hematopoietic stem cell transplantation


Publication History

Article published online:
11 August 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Jaiswal S, Fontanillas P, Flannick J. et al. Age-related clonal hematopoiesis associated with adverse outcomes. NEJM 2014; 371: 2488-2498
    CrossrefPubMedSearch in Google Scholar
  • 2 Genovese G, Kähler AK, Handsaker RE. et al. Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence. NEJM 2014; 371: 2477-2487
    CrossrefPubMedSearch in Google Scholar
  • 3 Xie M, Lu C, Wang J. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nature Med 2014; 20: 1472-1478
    CrossrefPubMedSearch in Google Scholar
  • 4 Arends CM, Galan-Sousa J, Hoyer K. et al. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis. Leukemia 2018; 32: 1908-1919
    CrossrefPubMedSearch in Google Scholar
  • 5 Coombs CC, Zehir A, Devlin SM. et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 2017; 21: 374-382.e374
    CrossrefPubMedSearch in Google Scholar
  • 6 Steensma DP, Bejar R, Jaiswal S. et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 2015; 126: 9-16
    CrossrefPubMedSearch in Google Scholar
  • 7 Shlush LI. Age-related clonal hematopoiesis. Blood 2018; 131: 496-504
    CrossrefPubMedSearch in Google Scholar
  • 8 Challen GA, Sun D, Jeong M. et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nature Genet 2011; 44: 23-31
    CrossrefPubMedSearch in Google Scholar
  • 9 Moran-Crusio K, Reavie L, Shih A. et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011; 20: 11-24
    CrossrefPubMedSearch in Google Scholar
  • 10 Abdel-Wahab O, Gao J, Adli M. et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. Journal of Experimental Medicine 2013; 210: 2641-2659
    CrossrefPubMedSearch in Google Scholar
  • 11 Jaiswal S, Natarajan P, Silver AJ. et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. NEJM 2017; 377: 111-121
    CrossrefPubMedSearch in Google Scholar
  • 12 Fuster JJ, MacLauchlan S, Zuriaga MA. et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 2017; 355: 842-847
    CrossrefPubMedSearch in Google Scholar
  • 13 Sano S, Oshima K, Wang Y. et al. CRISPR-Mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease. Circul Res 2018; 123: 335-341
    CrossrefPubMedSearch in Google Scholar
  • 14 SanMiguel JM, Young K, Trowbridge JJ. Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis. Experimental Hematology 2020; doi: 10.1016/j.exphem.2020.09.197
    CrossrefPubMedSearch in Google Scholar
  • 15 Bouzid H, Belk JA, Jan M. et al. Clonal hematopoiesis is associated with protection from Alzheimer’s disease. medRxiv 2021;
    CrossrefPubMedSearch in Google Scholar
  • 16 Abelson S, Collord G, Ng SWK. et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 2018; 559: 400-404
    CrossrefPubMedSearch in Google Scholar
  • 17 Desai P, Mencia-Trinchant N, Savenkov O. et al. Somatic mutations precede acute myeloid leukemia years before diagnosis. Nature Med 2018; 24: 1015-1023
    CrossrefPubMedSearch in Google Scholar
  • 18 Yoshizato T, Dumitriu B, Hosokawa K. et al. Somatic mutations and clonal hematopoiesis in aplastic anemia. NEJM 2015; 373: 35-47
    CrossrefPubMedSearch in Google Scholar
  • 19 Zhang CRC, Nix D, Gregory M. et al. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. Exp Hematol 2019; 80: 36-41.e33
    CrossrefPubMedSearch in Google Scholar
  • 20 Arends CM, Weiss M, Christen F. et al. Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Haematologica 2020; 105: e264-e267
    CrossrefPubMedSearch in Google Scholar
  • 21 Kim PG, Niroula A, Shkolnik V. et al. Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis. J Exp Med 2021; 218
    CrossrefPubMedSearch in Google Scholar
  • 22 Miller PG, Qiao D, Rojas-Quintero J. et al. Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood 2022; 139: 357-368
    CrossrefPubMedSearch in Google Scholar
  • 23 Vlasschaert C, McNaughton AJM, Chong M. et al. Association of clonal hematopoiesis of indeterminate potential with worse kidney function and anemia in two cohorts of patients with advanced chronic kidney disease. J Am Soc Nephrol 2022; 33: 985-995
    CrossrefPubMedSearch in Google Scholar
  • 24 Thakkar JP, McCarthy BJ, Villano JL. Age-specific cancer incidence rates increase through the oldest age groups. The American Journal of the Medical Sciences 2014; 348: 65-70
    CrossrefPubMedSearch in Google Scholar
  • 25 McNerney ME, Godley LA, Le Beau MM. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer 2017; 17: 513-527
    CrossrefPubMedSearch in Google Scholar
  • 26 Bolton KL, Ptashkin RN, Gao T. et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nature Genetics 2020; 52: 1219-1226
    CrossrefPubMedSearch in Google Scholar
  • 27 Arends CM, Dimitriou S, Stahler A. et al. Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trial. Blood 2022; 139: 1593-1597
    CrossrefPubMedSearch in Google Scholar
  • 28 Ortmann CA, Dorsheimer L, Abou-El-Ardat K. et al. Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation. Cell Reports 2019; 27: 2022-2028.e2023
    CrossrefPubMedSearch in Google Scholar
  • 29 Gibson CJ, Lindsley RC, Tchekmedyian V. et al. Clonal Hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. J Clin Oncol 2017; 35: 1598-1605
    CrossrefPubMedSearch in Google Scholar
  • 30 Husby S, Favero F, Nielsen C. et al. Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study. Leukemia 2020; 34: 3256-3268
    CrossrefPubMedSearch in Google Scholar
  • 31 Mouhieddine TH, Sperling AS, Redd R. et al. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nature Commun 2020; 11: 2996
    CrossrefPubMedSearch in Google Scholar
  • 32 Frick M, Chan W, Arends CM. et al. Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation. J Clin Oncol 2019; 37: 375-385
    CrossrefPubMedSearch in Google Scholar
  • 33 Gibson CJ, Kim HT, Zhao L. et al. Donor clonal hematopoiesis and recipient outcomes after transplantation. J Clin Oncol 2022; 40: 189-201
    CrossrefPubMedSearch in Google Scholar
  • 34 Oran B, Champlin RE, Wang F. et al. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation. Leukemia 2022; 36: 257-262
    CrossrefPubMedSearch in Google Scholar
  • 35 Gondek LP, Zheng G, Ghiaur G. et al. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation. Leukemia 2016; 30: 1916-1920
    CrossrefPubMedSearch in Google Scholar
  • 36 Svensson EC, Madar A, Campbell CD. et al. TET2-Driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol 2022;
    CrossrefPubMedSearch in Google Scholar